Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of antibody-drug conjugates for HR-positive and triple-negative metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Aug 16, 2024

Embed this episode

Attribution link and audio player

Ready to play

Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

0:00 54:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 54 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on August 16, 2024.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!